Device
Aerogen Solo®
Aerogen Solo® is a medical device with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
unknown125%
completed250%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation
NCT03464175
terminatedphase_2
Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia
NCT03749226
unknownnot_applicable
Assessment of SOLO Vibrating Mesh Nebulizer for Allergen-Induced Late Asthmatic Responses
NCT04630405
completednot_applicable
Inhaled Allergen Challenge Methodology: Assessment of a Vibrating Mesh Nebulizer for Allergen Administration
NCT03491358
Clinical Trials (4)
Showing 4 of 4 trials
NCT03464175Not Applicable
Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation
NCT03749226Phase 2
Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia
NCT04630405Not Applicable
Assessment of SOLO Vibrating Mesh Nebulizer for Allergen-Induced Late Asthmatic Responses
NCT03491358Not Applicable
Inhaled Allergen Challenge Methodology: Assessment of a Vibrating Mesh Nebulizer for Allergen Administration
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4